Evaluation and management of endocrine dysfunction in fibromyalgia.
about
Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents.Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatmentIs there an association between fibromyalgia and below-normal levels of urinary cortisol?Reduced hypothalamic-pituitary-adrenal axis activity in chronic multi-site musculoskeletal pain: partly masked by depressive and anxiety disorders.Fibromyalgia diagnosis: a review of the past, present and future.The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.Mindfulness training for reducing anger, anxiety, and depression in fibromyalgia patients.Fibromyalgia syndrome in need of effective treatments.Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.Delineating psychological and biomedical profiles in a heterogeneous fibromyalgia population using cluster analysis.The effect of fibromyalgia syndrome to gravidity, parity and duration of breastfeeding; A prospective study from Turkey.Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism.Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies.Muscle hypertrophy, strength development, and serum hormones during strength training in elderly women with fibromyalgia.Depression, sexuality and fibromyalgia syndrome: clinical findings and correlation to hematological parameters.Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators.
P2860
Q21195680-BCB67C5E-523E-4970-B40B-63134A77B5ABQ21296574-F180BEEA-ADA6-4738-A928-DE9969FE0F00Q33395139-0FDA4C33-EF3B-4082-857C-9726EB36BCE5Q33943543-C91629AD-FAB3-43DB-AA0D-7F3D399B379AQ34478961-DFF34E8B-D91C-427E-9C4A-AD42D6853748Q34622270-F55A4128-5EFF-4106-9C2C-950F60F1B13BQ34912415-95F95F83-D5EF-4A88-B4DA-F1264E9E6BF5Q36186172-F9F21899-85BC-4661-BFFB-934FF60209CAQ36618726-F50DDC4E-2762-48F5-88B5-1C7D385DC8B4Q36702690-5EC02FD0-784D-423F-9ECA-2A454EB5C961Q37055061-D5840263-E852-43DB-9F70-2359768F60FAQ37478926-42EC9138-9F3B-4C00-9D67-CC878BD35A7EQ37880195-6C7BFA27-3B60-48E1-A410-7EDB0556AC27Q46728685-5E8037DF-0BE7-44DE-A96C-B78480033CBDQ47930738-4D4BCFDD-6271-46A9-9639-AC09EB1AB903Q48606849-B9C63F14-B674-4ACC-84F1-C68635DB7956
P2860
Evaluation and management of endocrine dysfunction in fibromyalgia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evaluation and management of endocrine dysfunction in fibromyalgia.
@ast
Evaluation and management of endocrine dysfunction in fibromyalgia.
@en
Evaluation and management of endocrine dysfunction in fibromyalgia.
@nl
type
label
Evaluation and management of endocrine dysfunction in fibromyalgia.
@ast
Evaluation and management of endocrine dysfunction in fibromyalgia.
@en
Evaluation and management of endocrine dysfunction in fibromyalgia.
@nl
prefLabel
Evaluation and management of endocrine dysfunction in fibromyalgia.
@ast
Evaluation and management of endocrine dysfunction in fibromyalgia.
@en
Evaluation and management of endocrine dysfunction in fibromyalgia.
@nl
P2093
P1476
Evaluation and management of endocrine dysfunction in fibromyalgia.
@en
P2093
Johannes W G Jacobs
Johannes W J Bijlsma
Rinie Geenen
P304
P356
10.1016/S0889-857X(01)00009-6
P577
2002-05-01T00:00:00Z